This federal contract award, valued at $3,683.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Vimpat 10 mg/ml solution, a specialty medication used for the treatment of partial-onset seizures. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,805.53 firm fixed-price contract is for the supply of Vimpat 10 mg/ml solution in 200 ml containers. The order has a completion date of May 8, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $1,328.28 contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as a single awardee, with a potential value up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,179.55 firm fixed price contract is for the delivery of Vimpat 100 mg tablets. No set-aside requirement was specified. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Vimpat 10 mg/ml solution in 200 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,688.80, was awarded to the prime contractor Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award is a delivery order with a ceiling value of $3,734.94, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The order is for Vimpat 10 mg/ml solution, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2023. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles, with a ceiling value of $2,026.56 and an ultimate completion date of January 20, 2022. The contract is a firm fixed-price delivery order and was awarded on January 19, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $1,281.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, with a performance period ending on April 21, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,840.98, is for the supply of Vimpat 100 mg tablets to support military healthcare programs. It is a firm fixed-price contract with a period of performance through February 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $1,225.01 firm fixed price delivery order is for the supply of Vimpat 10 mg/ml solution, a pharmaceutical product. No set-aside designation was used for this award. The contract is a task order placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of...